Developer docs
API playgroundTry for free, no card

Search company profiles

Plair

Full company profile

uuid0003cjy

Namestring
Plair
Legal namestring
Plair SA
Websiteurl
plair.ch
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Plair SA is a Swiss instrumentation company founded in 2014 as a spin-off from the University of Geneva by PhD physicists Denis Kiselev and Svetlana Kiseleva. The company designs, manufactures, and commercializes laser-based instruments for continuous real-time measurements of fine airborne particles, combining patented light scattering morphology analysis with fluorescence spectroscopy. Its core products are the Rapid-C+ biofluorescent particle counter for pharmaceutical cleanroom monitoring and the Rapid-E+ intelligent bioaerosol sensor with integrated GPU-accelerated AI for research applications, supported by accessories (E-Catch, C-Catch), the PlairGrid model-building software, and a microbiological testing service offered at its Perly facility.

The company generates revenue primarily through hardware sales of analytical instruments and consumables, supplemented by professional microbiological testing and validation services. Distribution combines direct enterprise sales with strategic channel partnerships; the July 2025 Merck collaboration grants access to 100+ countries via Merck's Life Science network, and bioMérieux's March 2026 strategic investment (CHF 1M+) provides industry endorsement and board-level reach into pharmaceutical quality control channels. Pricing is quote-based and not publicly disclosed.

The primary customer segment is pharmaceutical manufacturers requiring EU GMP Annex 1-compliant environmental monitoring, with secondary applications in cosmetics, food and beverage, aerospace, and academic/environmental research. Plair holds validation under USP 1223, Ph. Eur. 5.1.6, and PDA TR No. 33 for alternative rapid microbiological methods, and the Rapid-E+ is ISO 21501-4:2018 compliant. The company operates with 1–10 employees from Perly, Switzerland, and has raised over CHF 3.7 million in grants and strategic investments through 2026.

Short descriptiontext

Plair SA is a Swiss instrumentation company that designs laser-based real-time particle detection systems—Rapid-C+ for pharmaceutical cleanroom monitoring and Rapid-E+ for bioaerosol research—serving pharmaceutical manufacturers, cosmetics, food and beverage, aerospace, and academic research customers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPlan-les-ouates, Switzerland
HQ citystring
Plan-les-ouates
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
air microbial monitoring, bioaerosol detection, cleanroom monitoring, viable particle counters, pharmaceutical environmental monitoring
Industry2 codes
PRIMARYAFALAEAD
Air & Aerosol Monitoring (Bioaerosols, Mold, Yeast, Airborne Pathogens)
Agriculture & Food Production/Food Safety, Testing & Certification/Environmental Monitoring & Hygiene Verification (Swabs, ATP, Pathogen Monitoring)
SECONDARYEUAHACAI
Microbiology & Pathogen Monitoring (Legionella, Coliform, HABs)
Energy, Utilities & Environment/Environmental Compliance, Monitoring & Consulting/Environmental Monitoring & Sampling (Air/Water/Soil/Noise)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Scientific Research and Development Services5417
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Services-Commercial Physical & Biological Research8731
Product category
Air Microbial Monitoring Instruments
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Instrument Sales
TypeHardware Sales
Description

Sale of analytical instruments including Rapid-C+ for pharmaceutical cleanroom monitoring and Rapid-E+ for research applications. Includes technical specifications and validation documentation for regulatory compliance.

plair.ch
2Accessories and Consumables
TypeHardware Sales
Description

E-Catch sampling units, C-Catch samplers, agar plates, and customized tubing for isolator integration.

plair.ch
3Microbiological Testing Services
TypeProfessional Services
Description

Laboratory services including BFPC testing and calibration, equivalence studies for alternative microbiological methods, and agar plate comparison studies. Rental of microbiological testing facility for customer performance qualification.

plair.ch
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Rapid-C+
Description

Advanced biofluorescent particle counter (BFPC) for real-time viable and total particle counting combined with continuous active air sampling for microbial identification. Designed for pharmaceutical environmental monitoring and cleanroom applications.

plair.ch
+3 more records
Core offering1 text field

Plair designs, manufactures and commercializes real-time air microbial detection instruments for pharmaceutical cleanroom and bioaerosol research applications. Its core products are the Rapid-C+ biofluorescent particle counter, which combines real-time viable and total particle counting with certified continuous agar media sampling for microbial identification, and the Rapid-E+ intelligent bioaerosol sensor using patented laser-based light scattering and fluorescence spectroscopy with GPU-accelerated AI.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 46,000 tCO2e potential annual savings in aseptic filling lines, 45,000 tCO2e in nursing/elderly homes, 53,000 tCO2e in shared office spaces
+2 more records
Product overview1 text field

Plair SA is a Swiss company specializing in real-time air microbial monitoring and bioaerosol detection. The product portfolio centers on three main instrument lines: Rapid-C+ (real-time viable particle counter for pharmaceutical cleanroom monitoring), Rapid-E+ (intelligent bioaerosol sensor for research), and Rapid-E (legacy outdoor pollen monitor). These core instruments are complemented by the E-Catch sampling accessory for Rapid-E+ and C-Catch aseptic sampler for Rapid-C+. The company also offers PlairGrid software for data analysis and provides microbiological testing and validation services through its specialized bioaerosol testing facility. Plair's technology combines laser-based light scattering analysis with fluorescence spectroscopy for particle detection and classification.

Product and service6 records
1Rapid-C+ Biofluorescent Particle Counter
CategoryReal-time viable particle counter
Description

Real-time viable and total particle counter (biofluorescent particle counter / BFPC) that combines patented optical detection of viable and total particles with certified continuous active air sampling on standard agar media for microbial identification. Designed for pharmaceutical cleanroom environmental monitoring under EU GMP Annex 1, with a 5 L/min flow rate and detection from 0.5 µm to 100 µm.

2Rapid-E+ Intelligent Bioaerosol Sensor
CategoryBioaerosol sensor for research
Description

Intelligent bioaerosol sensor using patented laser technology with GPU-accelerated AI for real-time single-particle analysis from 0.3 to 100 µm, including bacteria, fungal spores, viruses, pollen and particulate matter. Built for research and environmental monitoring applications.

3E-Catch Airborne Particle Sampling Unit
CategoryAir sampling accessory
Description

Automated accessory for Rapid-E+ providing 10 reusable sampling plates for traditional lab-based analysis of airborne particles. Operates at 5 L/min with low power consumption and independent plate introduction for time-resolved bioaerosol collection.

4Rapid-E Real-Time Pollen Monitor
CategoryLegacy outdoor pollen monitor
Description

Legacy instrument providing accurate, automatic and real-time pollen monitoring per species using light scattering and fluorescence spectroscopy. Placed Plair as the originator of network-connected, real-time pollen monitoring.

5Rapid-C Real-Time Viable Particle Detector
CategoryLegacy cleanroom viable particle detector
Description

Predecessor of Rapid-C+ providing real-time viable particle detection for indoor air contamination monitoring in cleanrooms, now superseded by the integrated Rapid-C+ but still referenced for existing deployments.

6Microbiological Testing Services
CategoryMicrobiological validation and testing services
Description

State-of-the-art microbiological testing solutions including biofluorescent particle counter (BFPC) testing and calibration, equivalence studies for alternative and rapid microbiological methods, agar plate comparison studies, and rental of a unique bioaerosol testing facility with a 30-cubic-meter aerosol chamber for instrument validation.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-07-23
Description

Plair SA and Merck signed a major collaboration agreement to bring Rapid-C+ to 100+ countries worldwide. This partnership represents a significant expansion of Plair's global reach and enables better serving the growing Life Science demand for real-time monitoring and viable particle counters.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-11-02
Description

Strategic partnership between Plair SA and MBV AG (Swiss global leader in viable air sampling with MAS-100 series) to develop next-generation automated solutions for microbiology monitoring combining both companies' technologies. NewGen Holding AG (MBV parent) invested in Plair's share capital, and Ronny Zingre (MBV CEO) joined Plair's Board of Directors.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Lighthouse is a direct competitor in pharmaceutical and cleanroom particle counters, offering remote and benchtop counters as well as microbial air samplers. Its Apex and ActiveCount lines overlap with Plair's pharmaceutical environmental monitoring offering.

TypeDirect peer
Description

Particle Measuring Systems is a leading global manufacturer of cleanroom particle counters and environmental monitoring instruments, directly competing with Plair's Rapid-C+ in pharmaceutical Grade A/B monitoring. Its Lasair III and IsoAir lines overlap with Plair's cleanroom monitoring value proposition.

TypeBroad incumbent
Description

Thermo Fisher is a broad life sciences tools incumbent offering particle counters, environmental monitoring services, and microbiological testing products. It overlaps with Plair through its pharma QC and laboratory services portfolio rather than as a specialized airborne particle counter.

TypeDirect peer
Description

TSI manufactures aerosol and particle instrumentation including bioaerosol detectors and optical particle counters used in pharmaceutical, research, and indoor air quality applications. Its products compete with both Plair's Rapid-C+ (cleanroom) and Rapid-E+ (research bioaerosol) lines.

TypeDirect peer
Description

Bertin Instruments produces the Coriolis Compact and Coriolis Micro bioaerosol samplers used in pharmaceutical and environmental microbial monitoring. Comparable technology focus on air-microbial capture and laboratory analysis for life sciences applications.

TypeBroad incumbent
Description

bioMérieux is the global leader in in vitro diagnostics and a major player in industrial microbiology. While not a direct competitor in airborne particle counting, it is Plair's strategic investor and is expanding into pharmaceutical QC adjacent to Plair's monitoring use cases.

TypeBroad incumbent
Description

Beckman Coulter offers a broad life sciences instrumentation portfolio including cell and particle analyzers (e.g., MET ONE) used in pharmaceutical QC. It does not specialize exclusively in viable airborne particle counting but competes in adjacent pharma QC workflows.

TypeEmerging player
Description

Aerosol Devices develops advanced bioaerosol collection technologies (e.g., the Spot Sampler) for research and environmental monitoring. Comparable focus on real-time and high-efficiency airborne bioaerosol capture for life sciences and atmospheric research applications.

TypeDirect peer
Description

Climet is a manufacturer of cleanroom particle counters (CI series) used in pharmaceutical and semiconductor environmental monitoring. Direct competitor in pharmaceutical-grade particle counting hardware.

TypeDirect peer
Description

MBV AG is the global leader in viable air sampling with its MAS-100 series of impaction air samplers used in pharmaceutical cleanrooms. MBV is both a Plair partner and an investor, and its products are directly adjacent to (and now integrated with) Plair's C-Catch component.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Plair

Air Microbial Monitoring Instrumentsplair.ch

Plair SA is a Swiss instrumentation company that designs laser-based real-time particle detection systems—Rapid-C+ for pharmaceutical cleanroom monitoring and Rapid-E+ for bioaerosol research—serving pharmaceutical manufacturers, cosmetics, food and beverage, aerospace, and academic research customers globally.

What Plair does

Plair SA is a Swiss instrumentation company founded in 2014 as a spin-off from the University of Geneva by PhD physicists Denis Kiselev and Svetlana Kiseleva. The company designs, manufactures, and commercializes laser-based instruments for continuous real-time measurements of fine airborne particles, combining patented light scattering morphology analysis with fluorescence spectroscopy. Its core products are the Rapid-C+ biofluorescent particle counter for pharmaceutical cleanroom monitoring and the Rapid-E+ intelligent bioaerosol sensor with integrated GPU-accelerated AI for research applications, supported by accessories (E-Catch, C-Catch), the PlairGrid model-building software, and a microbiological testing service offered at its Perly facility.

The company generates revenue primarily through hardware sales of analytical instruments and consumables, supplemented by professional microbiological testing and validation services. Distribution combines direct enterprise sales with strategic channel partnerships; the July 2025 Merck collaboration grants access to 100+ countries via Merck's Life Science network, and bioMérieux's March 2026 strategic investment (CHF 1M+) provides industry endorsement and board-level reach into pharmaceutical quality control channels. Pricing is quote-based and not publicly disclosed.

The primary customer segment is pharmaceutical manufacturers requiring EU GMP Annex 1-compliant environmental monitoring, with secondary applications in cosmetics, food and beverage, aerospace, and academic/environmental research. Plair holds validation under USP 1223, Ph. Eur. 5.1.6, and PDA TR No. 33 for alternative rapid microbiological methods, and the Rapid-E+ is ISO 21501-4:2018 compliant. The company operates with 1–10 employees from Perly, Switzerland, and has raised over CHF 3.7 million in grants and strategic investments through 2026.

Plair firmographics

Firmographics
Name
Plair
Legal name
Plair SA
Website
https://plair.ch
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Plair SA is a Swiss instrumentation company that designs laser-based real-time particle detection systems—Rapid-C+ for pharmaceutical cleanroom monitoring and Rapid-E+ for bioaerosol research—serving pharmaceutical manufacturers, cosmetics, food and beverage, aerospace, and academic research customers globally.
Ownership category
akta.pro rank

Plair industry classification

Industry
Product category
Air Microbial Monitoring Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417)
SIC
Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYAFALAEAD
Air & Aerosol Monitoring (Bioaerosols, Mold, Yeast, Airborne Pathogens)
Agriculture & Food Production/Food Safety, Testing & Certification/Environmental Monitoring & Hygiene Verification (Swabs, ATP, Pathogen Monitoring)
SECONDARYEUAHACAI
Microbiology & Pathogen Monitoring (Legionella, Coliform, HABs)
Energy, Utilities & Environment/Environmental Compliance, Monitoring & Consulting/Environmental Monitoring & Sampling (Air/Water/Soil/Noise)

Keywords

  • Air microbial monitoring
  • Bioaerosol detection
  • Cleanroom monitoring
  • Viable particle counters
  • Pharmaceutical environmental monitoring

Where Plair is headquartered

Location

Headquarters

HQ city
Plan-les-ouates
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

Plair business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Instrument Sales: Sale of analytical instruments including Rapid-C+ for pharmaceutical cleanroom monitoring and Rapid-E+ for research applications. Includes technical specifications and validation documentation for regulatory compliance.
  2. Accessories and Consumables: E-Catch sampling units, C-Catch samplers, agar plates, and customized tubing for isolator integration.
  3. Microbiological Testing Services: Laboratory services including BFPC testing and calibration, equivalence studies for alternative microbiological methods, and agar plate comparison studies. Rental of microbiological testing facility for customer performance qualification.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Plair product offering

Product offering

Core offering

Plair designs, manufactures and commercializes real-time air microbial detection instruments for pharmaceutical cleanroom and bioaerosol research applications. Its core products are the Rapid-C+ biofluorescent particle counter, which combines real-time viable and total particle counting with certified continuous agar media sampling for microbial identification, and the Rapid-E+ intelligent bioaerosol sensor using patented laser-based light scattering and fluorescence spectroscopy with GPU-accelerated AI.

Product overview

Plair SA is a Swiss company specializing in real-time air microbial monitoring and bioaerosol detection. The product portfolio centers on three main instrument lines: Rapid-C+ (real-time viable particle counter for pharmaceutical cleanroom monitoring), Rapid-E+ (intelligent bioaerosol sensor for research), and Rapid-E (legacy outdoor pollen monitor). These core instruments are complemented by the E-Catch sampling accessory for Rapid-E+ and C-Catch aseptic sampler for Rapid-C+. The company also offers PlairGrid software for data analysis and provides microbiological testing and validation services through its specialized bioaerosol testing facility. Plair's technology combines laser-based light scattering analysis with fluorescence spectroscopy for particle detection and classification.

Differentiator

Problem solved

Functional benefit

Brands

  • Rapid-C+: Advanced biofluorescent particle counter (BFPC) for real-time viable and total particle counting combined with continuous active air sampling for microbial identification. Designed for pharmaceutical environmental monitoring and cleanroom applications.
  • Rapid-E+
  • E-Catch
  • C-Catch

Products and services

  • Rapid-C+ Biofluorescent Particle Counter Real-time viable and total particle counter (biofluorescent particle counter / BFPC) that combines patented optical detection of viable and total particles with certified continuous active air sampling on standard agar media for microbial identification. Designed for pharmaceutical cleanroom environmental monitoring under EU GMP Annex 1, with a 5 L/min flow rate and detection from 0.5 µm to 100 µm.
  • Rapid-E+ Intelligent Bioaerosol Sensor Intelligent bioaerosol sensor using patented laser technology with GPU-accelerated AI for real-time single-particle analysis from 0.3 to 100 µm, including bacteria, fungal spores, viruses, pollen and particulate matter. Built for research and environmental monitoring applications.
  • E-Catch Airborne Particle Sampling Unit Automated accessory for Rapid-E+ providing 10 reusable sampling plates for traditional lab-based analysis of airborne particles. Operates at 5 L/min with low power consumption and independent plate introduction for time-resolved bioaerosol collection.
  • Rapid-E Real-Time Pollen Monitor Legacy instrument providing accurate, automatic and real-time pollen monitoring per species using light scattering and fluorescence spectroscopy. Placed Plair as the originator of network-connected, real-time pollen monitoring.
  • Rapid-C Real-Time Viable Particle Detector Predecessor of Rapid-C+ providing real-time viable particle detection for indoor air contamination monitoring in cleanrooms, now superseded by the integrated Rapid-C+ but still referenced for existing deployments.
  • Microbiological Testing Services State-of-the-art microbiological testing solutions including biofluorescent particle counter (BFPC) testing and calibration, equivalence studies for alternative and rapid microbiological methods, agar plate comparison studies, and rental of a unique bioaerosol testing facility with a 30-cubic-meter aerosol chamber for instrument validation.

Quantifiable outcome

  • 46,000 tCO2e potential annual savings in aseptic filling lines, 45,000 tCO2e in nursing/elderly homes, 53,000 tCO2e in shared office spaces
  • +2 more outcomes

Companies that use Plair

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Plair technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Plair partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • MerckcoreChannel Partner/ Reseller/ Distributor · 23 July 2025Plair SA and Merck signed a major collaboration agreement to bring Rapid-C+ to 100+ countries worldwide. This partnership represents a significant expansion of Plair's global reach and enables better serving the growing Life Science demand for real-time monitoring and viable particle counters.
  • MBV AGcoreStrategic or Co-development Partner · 2 November 2020Strategic partnership between Plair SA and MBV AG (Swiss global leader in viable air sampling with MAS-100 series) to develop next-generation automated solutions for microbiology monitoring combining both companies' technologies. NewGen Holding AG (MBV parent) invested in Plair's share capital, and Ronny Zingre (MBV CEO) joined Plair's Board of Directors.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Plair competitors and assessment

Company assessment

Direct peers

  • Lighthouse Worldwide Solutions: Lighthouse is a direct competitor in pharmaceutical and cleanroom particle counters, offering remote and benchtop counters as well as microbial air samplers. Its Apex and ActiveCount lines overlap with Plair's pharmaceutical environmental monitoring offering.
  • Particle Measuring Systems: Particle Measuring Systems is a leading global manufacturer of cleanroom particle counters and environmental monitoring instruments, directly competing with Plair's Rapid-C+ in pharmaceutical Grade A/B monitoring. Its Lasair III and IsoAir lines overlap with Plair's cleanroom monitoring value proposition.
  • TSI Incorporated: TSI manufactures aerosol and particle instrumentation including bioaerosol detectors and optical particle counters used in pharmaceutical, research, and indoor air quality applications. Its products compete with both Plair's Rapid-C+ (cleanroom) and Rapid-E+ (research bioaerosol) lines.
  • Bertin Technologies: Bertin Instruments produces the Coriolis Compact and Coriolis Micro bioaerosol samplers used in pharmaceutical and environmental microbial monitoring. Comparable technology focus on air-microbial capture and laboratory analysis for life sciences applications.
  • Climet Instruments: Climet is a manufacturer of cleanroom particle counters (CI series) used in pharmaceutical and semiconductor environmental monitoring. Direct competitor in pharmaceutical-grade particle counting hardware.
  • MBV AG: MBV AG is the global leader in viable air sampling with its MAS-100 series of impaction air samplers used in pharmaceutical cleanrooms. MBV is both a Plair partner and an investor, and its products are directly adjacent to (and now integrated with) Plair's C-Catch component.

Broad incumbents

  • Thermo Fisher Scientific: Thermo Fisher is a broad life sciences tools incumbent offering particle counters, environmental monitoring services, and microbiological testing products. It overlaps with Plair through its pharma QC and laboratory services portfolio rather than as a specialized airborne particle counter.
  • bioMérieux: bioMérieux is the global leader in in vitro diagnostics and a major player in industrial microbiology. While not a direct competitor in airborne particle counting, it is Plair's strategic investor and is expanding into pharmaceutical QC adjacent to Plair's monitoring use cases.
  • Beckman Coulter Life Sciences: Beckman Coulter offers a broad life sciences instrumentation portfolio including cell and particle analyzers (e.g., MET ONE) used in pharmaceutical QC. It does not specialize exclusively in viable airborne particle counting but competes in adjacent pharma QC workflows.

Emerging players

  • Aerosol Devices: Aerosol Devices develops advanced bioaerosol collection technologies (e.g., the Spot Sampler) for research and environmental monitoring. Comparable focus on real-time and high-efficiency airborne bioaerosol capture for life sciences and atmospheric research applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Plair social profiles

Digital presence

Plair compliance and trust

Trust signal

Compliance5 records

Plair financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Plair leadership team

Management profile

Number of profiles

Profiles4 records

Plair funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Plair M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Plair

What does Plair do?

Plair designs, manufactures and commercializes real-time air microbial detection instruments for pharmaceutical cleanroom and bioaerosol research applications. Its core products are the Rapid-C+ biofluorescent particle counter, which combines real-time viable and total particle counting with certified continuous agar media sampling for microbial identification, and the Rapid-E+ intelligent bioaerosol sensor using patented laser-based light scattering and fluorescence spectroscopy with GPU-accelerated AI.

Is Plair a public or private company?

Plair is a private company. It is classified as venture growth investor backed and is currently operating.

When was Plair founded?

Plair was founded in 2014. It employs 11 to 50 people.

Where is Plair based?

Plair is headquartered in Plan-les-ouates, Switzerland, in the Europe region.

How does Plair make money?

Three revenue lines are on record. Instrument Sales are the primary driver. The others are accessories and Consumables and microbiological Testing Services.

Who are Plair's main competitors?

Direct peers on record are Lighthouse Worldwide Solutions, Particle Measuring Systems, TSI Incorporated, Bertin Technologies, Climet Instruments and MBV AG. Broad incumbents are Thermo Fisher Scientific, bioMérieux and Beckman Coulter Life Sciences. Aerosol Devices is listed as an emerging player.

Does Plair have an API?

No public API is recorded for Plair.

What industry is Plair in?

Plair's product category is Air Microbial Monitoring Instruments. Its primary akta.pro industry code is AFALAEAD, Air & Aerosol Monitoring (Bioaerosols, Mold, Yeast, Airborne Pathogens), with a secondary code of EUAHACAI, Microbiology & Pathogen Monitoring (Legionella, Coliform, HABs). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrtimesAir Particle Tracking Solution Market Share, Trends, Analysis and Forecast Outlook to 2031 – PR TimesThe Air Particle Tracking Solution Market is experiencing significant growth as industries across pharmaceuticals, semiconductors, and healthcare increase investments in contamination control and environmental monitoring. bioMérieux announced an investment in Plair to accelerate real-time microbial detection and airborne particle monitoring for pharmaceutical cleanrooms, highlighting strategic consolidation in the sector. The market outlook through 2031 remains positive, driven by advancements in AI, IoT-enabled sensors, and cloud-based monitoring platforms as organizations prioritize quality assurance and regulatory compliance.Greater Geneva Bern area (GGBa)Top Stories from Western Switzerland (March 2026)Western Switzerland reported several landmark developments in March 2026, including a 30.02% solar cell efficiency world record by EPFL and CSEM researchers, and Mondelēz International's CHF 65 million investment in its Bern facility to increase Toblerone global production capacity by 20–30%. Foreign direct investment in the Greater Geneva Bern area supported 91 company establishments expected to create 740 jobs, while bioMérieux invested over CHF 1 million in Geneva-based Plair to expand its real-time microbial detection capabilities.BioAlpsbioMérieux Invests CHF 1 Million in PlairbioMérieux has invested over CHF 1 million in Plair, a University of Geneva spinoff headquartered in Geneva, Switzerland, that offers real-time microbial detection solutions for the pharmaceutical industry. Plair's flagship product, RAPID-C+, is a real-time viable particle counter for pharmaceutical environmental monitoring and is already commercially available. As part of the investment, bioMérieux's Senior Vice President of Pharma Quality Control Michael Reynier will join Plair's Board of Directors.Venture KickPlair raises CHF 1 million to expand real-time microbial detectionGeneva-based Plair has raised CHF 1 million from bioMérieux, a global in vitro diagnostics leader, to accelerate the global rollout of its RAPID-C+ real-time particle counter for microbial detection in pharmaceutical cleanrooms. The investment supports bioMérieux's strategy to strengthen its Pharma Quality Control offerings while leveraging over 60 years of scientific expertise. Plair will continue expanding through its global network of partners and distributors as it scales commercial deployment of the technology.startupticker.chPlair attracts investment from bioMérieuxbioMérieux has invested more than CHF 1 million in Plair, a Geneva-based scale-up company, as a strategic partnership to advance pharmaceutical quality control and environmental monitoring. As part of the deal, bioMérieux Senior Vice President Michael Reynier will join Plair's Board of Directors, and the investment is described as endorsing Plair's flagship product RAPID-C+, a real-time viable particle counter for cleanroom monitoring that is already commercially available. The partnership is intended to accelerate adoption of the technology in pharmaceutical manufacturing worldwide and sets the stage for bioMérieux to expand its portfolio in the sector.BiomerieuxbioMérieux Invests in Plair to Advance Real-Time Environmental Monitoring for Pharmaceutical IndustrybioMérieux has invested over one million Swiss Francs in Plair, a Geneva-based scale-up company, to advance Plair's RAPID-C+ real-time viable particle counter technology for pharmaceutical environmental monitoring. As part of the deal, bioMérieux Senior Vice President Michael Reynier will join Plair's Board of Directors, and the investment reinforces bioMérieux's strategy to strengthen its Pharma Quality Control offering through partnerships. The RAPID-C+ technology combines real-time counting of viable and total particles with certified continuous sampling on standard agar media, enabling faster microbial detection in cleanroom environments.PlairPLAIR welcomes bioMérieux as a Strategic Investor Reinforcing Global Adoption of RAPID-C+PLAIR, a Geneva-based pharmaceutical environmental monitoring scale-up, announced a strategic investment from bioMérieux, a global leader in in vitro diagnostics, to reinforce global adoption of its RAPID-C+ Biofluorescent Particle Counter technology. The investment represents an industry endorsement of RAPID-C+ as a breakthrough innovation for real-time cleanroom monitoring, with bioMérieux positioning the partnership as a step toward advancing pharmaceutical quality control. The companies aim to accelerate BFPC market adoption by providing quality managers and microbiologists with real-time viable particle counting solutions for critical cleanroom environments.startupticker.chFIF Funding for three new Geneva projectsThe Fongit Innovation Fund (FIF) awarded financing to three Geneva-based entities, including growth and seed loans to startups Plair SA and Endotelix Diagnostics Sàrl, and a grant to Dr. Beat Walpoth for cardiovascular research. The fund is supported by the State of Geneva, the Geneva Chamber of Commerce, the UN International Trade Center, and the UN Environment agency to foster innovation aligned with Sustainable Development Goals.startupticker.chPlair to market next-gen air microbial detection with MBVPlair and MBV signed a collaboration agreement to develop next-generation air microbial detection solutions, with MBV's parent NewGen Holding investing in Plair. Ronny Zingre, MBV's CEO, will join Plair's board. The partnership aims to combine Plair's laser-based bioaerosol monitoring with MBV's viable air sampling expertise.startupticker.chPlair launches second product line for biocontamination monitoringPlair launched Rapid-C, a real-time viable particle detector for indoor environments, building on its earlier Rapid-E product. The device uses light scattering and fluorescence spectroscopy to count viable particles with up to 99% accuracy, requiring no human intervention.